A carregar...
Updated Product Label Allows Home Administration of Omacetaxine Mepesuccinate
The U.S. Food and Drug Administration’s accelerated approval of omacetaxine mepesuccinate for the treatment of chronic-phase or accelerated-phase chronic myeloid leukemia has been converted to full approval. Approved changes to the omacetaxine administration guidelines to allow home administration u...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4221374/ https://ncbi.nlm.nih.gov/pubmed/25280490 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0230 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|